It is important to recognize that the higher risk of HF in EGFR-mutated NSCLC patients may stem from a combination of factors, including older age, pre-existing cardiac conditions, and other comorbidities commonly observed in real-world patients. Here, EGFR is linked to hydrops fetalis.